- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 59/265 - Citric acid
Patent holdings for IPC class C07C 59/265
Total number of patents in this class: 197
10-year publication summary
|
23
|
22
|
18
|
14
|
23
|
13
|
22
|
11
|
22
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 128 |
6 |
| Oyster Point Pharma, Inc. | 79 |
6 |
| Purac Biochem B.V. | 477 |
6 |
| VeroScience LLC | 69 |
6 |
| Novartis AG | 10262 |
4 |
| Beachbody, LLC | 615 |
4 |
| Tokuyama Corporation | 1477 |
4 |
| Nantong Feiyu Fine Chemical Co., Ltd | 5 |
4 |
| Takeda Pharmaceutical Company Limited | 2712 |
3 |
| Anhui BBCA Fermentation Technology Engineering Research Co., Ltd. | 5 |
3 |
| Apotex Inc. | 203 |
3 |
| Gilead Sciences, Inc. | 2222 |
3 |
| Glykon Technologies Group, LLC | 13 |
3 |
| Scynexis, Inc. | 68 |
3 |
| Totus Medicines Inc. | 23 |
3 |
| Ossifi Therapeutics LLC | 12 |
3 |
| Bristol-myers Squibb Company | 4742 |
2 |
| Vertex Pharmaceuticals Incorporated | 1582 |
2 |
| Balchem Corporation | 85 |
2 |
| Celgene Corporation | 1410 |
2 |
| Other owners | 125 |